Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm

Journal of Pediatrics

Volumn 147, Issue 3 SUPPL., 2005, Pages

  Parad, Richard B ^a   Comeau, Anne Marie ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ALGORITHM; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DNA SCREENING; GENE MUTATION; HUMAN; IMMUNOREACTIVITY; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ALGORITHMS; CHLORIDES; CLINICAL PROTOCOLS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DECISION TREES; DNA MUTATIONAL ANALYSIS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; MASSACHUSETTS; MUTATION; NEONATAL SCREENING; PRACTICE GUIDELINES; SWEAT; TRYPSINOGEN;

EID: 25844530785     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.08.017     Document Type: Conference Paper

References (15)

1. J.R. Crossley, R.B. Elliott, and P.A. Smith Dried-blood spot screening for cystic fibrosis in the newborn Lancet 1 1979 472 474
2. K.B. Hammond, S.H. Abman, R.J. Sokol, and F.J. Accurso Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentration N Engl J Med 325 1991 769 774
3. R.G. Gregg, B.S. Wilfond, P.M. Farrell, A. Laxova, D. Hassemer, and E.H. Mischler Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols Am J Hum Genet 52 1993 616 626
4. R.G. Gregg, A. Simantel, P.M. Farrell, R. Koscik, M.R. Kosorok, and A. Laxova Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods Pediatrics 99 1997 819 824
5. A.M. Comeau, R.B. Parad, H.L. Dorkin, M. Dovey, R. Gerstle, and K. Haver Optimizing cystic fibrosis newborn screening in heterogeneous populations with multiple-mutation testing Pediatrics 113 2004 1573 1581
6. R.B. Parad, and A.M. Comeau Cystic fibrosis newborn screening Pediatr Ann 32 2003 528 535
7. NCCLS Sweat testing: sample collection and quantitative analysis; approved guideline. 2nd ed. NCCLS document C34-A2 [ISBN 1-56238-407-4] 2000 NCCLS Wayne, Pa
8. P.M. Farrell, and R.E. Koscik Sweat chloride concentrations in infants homozygous or heterozygous for ΔF508 cystic fibrosis Pediatrics 97 1996 524 528
9. E. Elian, H. Shwachman, and W.H. Hendren Intestinal obstruction of the newborn infant: usefulness of the sweat electrolyte test in differential diagnosis N Engl J Med 264 1961 13 16
10. R. Padoan, A. Bassotti, M. Seia, and C. Corbetta Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations Eur J Pediatr 161 2002 212 215
11. K.H. Gan, H.J. Veeze, A.M. Van den Ouweland, D.J. Halley, H. Scheffer, and A. van der Hout A cystic fibrosis mutation associated with mild lung disease N Engl J Med 333 1995 95 99
12. E. Kerem, M. Nissim-Rafinia, Z. Argaman, A. Augarten, L. Bentur, and A. Klar A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype Pediatrics 100 1997 E5
13. -channels with altered pore properties Nature 362 1993 160 164
14. B.J. Rosenstein, and G.R. Cutting The diagnosis of cystic fibrosis: a consensus statement J Pediatr 134 1998 589 595
15. L. Ellis, E. Tullis, M. Corey, J. Zielenski, L. Tsui, and S. Martin R117H (7T) can be associated with a CF diagnosis [abstract] Pediatr Pulmonol S24 2002 228